This page answers frequently asked questions (FAQ) about drug shortages such as what is a drug shortage, how many per year, how the FDA addresses and takes action on shortages, how the FDA notifies the public, what manufacturers are supposed to report to the FDA, and reasons for many drug shortages
Similar Posts
Pushclean Technology Plastik Sanayi Ve Ticaret Ltd. Sirketi – 709156 – 06/16/2025
CGMP/Finished Pharmaceuticals/AdulteratedWeaver Nut Company Inc., Issues Allergy Alert on Undeclared Milk in Chocolate Nonpareils
Weaver Nut Company, Inc. is recalling the following chocolate products with specific lot codes, due to potential undeclared milk allergens. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reactions if they consume the impacted products anMedi-Fare Drug Pharmaceutical Compounding LLC. Blacksburg, SC. 483 issued 06/06/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 06/06/2025
Short Title (70 char) Medi-Fare Drug Pharmaceutical Compounding LLC. Blacksburg, SC. 483 issued 06/06/2025
FEI Number 3009925820
Firm Name Medi-Fare Drug Pharmaceutical Compounding LLC
Record Type 483Slendid – 09/09/2025
Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetCDER/Office of New Drugs Streamlined Nonclinical Studies and Acceptable New Approach Methodologies (NAMs)
It has become increasingly clear that new approach methodologies (NAMs)—when combined with knowledge of the pathway, results of pharmacology studies, and other relevant data—may offer ways to reduce animal testing.Selective Safety Data Collection (SSDC) Demonstration Project
Offers an innovative approach to facilitate the conduct of large-scale efficacy and safety trials through the purposeful reduction in the collection of certain types of data for drugs or biologics with a well-characterized safety profile.